[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pemetrexed Drug Market Research Report 2023(Status and Outlook)

April 2023 | 113 pages | ID: GADC2371B84BEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
Bosson Research’s latest report provides a deep insight into the global Pemetrexed Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pemetrexed Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pemetrexed Drug market in any manner.
Global Pemetrexed Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Biocon

Market Segmentation (by Type)
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial

Market Segmentation (by Application)
Pleural mesothelioma
Non-small cell lung cancer

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pemetrexed Drug Market
Overview of the regional outlook of the Pemetrexed Drug Market:

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pemetrexed Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pemetrexed Drug
1.2 Key Market Segments
  1.2.1 Pemetrexed Drug Segment by Type
  1.2.2 Pemetrexed Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PEMETREXED DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pemetrexed Drug Market Size (M USD) Estimates and Forecasts (2018-2029)
  2.1.2 Global Pemetrexed Drug Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PEMETREXED DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Global Pemetrexed Drug Sales by Manufacturers (2018-2023)
3.2 Global Pemetrexed Drug Revenue Market Share by Manufacturers (2018-2023)
3.3 Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pemetrexed Drug Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pemetrexed Drug Sales Sites, Area Served, Product Type
3.6 Pemetrexed Drug Market Competitive Situation and Trends
  3.6.1 Pemetrexed Drug Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Pemetrexed Drug Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PEMETREXED DRUG INDUSTRY CHAIN ANALYSIS

4.1 Pemetrexed Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEMETREXED DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 PEMETREXED DRUG MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
6.3 Global Pemetrexed Drug Market Size Market Share by Type (2018-2023)
6.4 Global Pemetrexed Drug Price by Type (2018-2023)

7 PEMETREXED DRUG MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pemetrexed Drug Market Sales by Application (2018-2023)
7.3 Global Pemetrexed Drug Market Size (M USD) by Application (2018-2023)
7.4 Global Pemetrexed Drug Sales Growth Rate by Application (2018-2023)

8 PEMETREXED DRUG MARKET SEGMENTATION BY REGION

8.1 Global Pemetrexed Drug Sales by Region
  8.1.1 Global Pemetrexed Drug Sales by Region
  8.1.2 Global Pemetrexed Drug Sales Market Share by Region
8.2 North America
  8.2.1 North America Pemetrexed Drug Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Pemetrexed Drug Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Pemetrexed Drug Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Pemetrexed Drug Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Pemetrexed Drug Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Eli Lilly and Company
  9.1.1 Eli Lilly and Company Pemetrexed Drug Basic Information
  9.1.2 Eli Lilly and Company Pemetrexed Drug Product Overview
  9.1.3 Eli Lilly and Company Pemetrexed Drug Product Market Performance
  9.1.4 Eli Lilly and Company Business Overview
  9.1.5 Eli Lilly and Company Pemetrexed Drug SWOT Analysis
  9.1.6 Eli Lilly and Company Recent Developments
9.2 Pfizer
  9.2.1 Pfizer Pemetrexed Drug Basic Information
  9.2.2 Pfizer Pemetrexed Drug Product Overview
  9.2.3 Pfizer Pemetrexed Drug Product Market Performance
  9.2.4 Pfizer Business Overview
  9.2.5 Pfizer Pemetrexed Drug SWOT Analysis
  9.2.6 Pfizer Recent Developments
9.3 Teva
  9.3.1 Teva Pemetrexed Drug Basic Information
  9.3.2 Teva Pemetrexed Drug Product Overview
  9.3.3 Teva Pemetrexed Drug Product Market Performance
  9.3.4 Teva Business Overview
  9.3.5 Teva Pemetrexed Drug SWOT Analysis
  9.3.6 Teva Recent Developments
9.4 Eagle Pharmaceuticals
  9.4.1 Eagle Pharmaceuticals Pemetrexed Drug Basic Information
  9.4.2 Eagle Pharmaceuticals Pemetrexed Drug Product Overview
  9.4.3 Eagle Pharmaceuticals Pemetrexed Drug Product Market Performance
  9.4.4 Eagle Pharmaceuticals Business Overview
  9.4.5 Eagle Pharmaceuticals Pemetrexed Drug SWOT Analysis
  9.4.6 Eagle Pharmaceuticals Recent Developments
9.5 APOTEX
  9.5.1 APOTEX Pemetrexed Drug Basic Information
  9.5.2 APOTEX Pemetrexed Drug Product Overview
  9.5.3 APOTEX Pemetrexed Drug Product Market Performance
  9.5.4 APOTEX Business Overview
  9.5.5 APOTEX Pemetrexed Drug SWOT Analysis
  9.5.6 APOTEX Recent Developments
9.6 Qilu Pharmaceutical
  9.6.1 Qilu Pharmaceutical Pemetrexed Drug Basic Information
  9.6.2 Qilu Pharmaceutical Pemetrexed Drug Product Overview
  9.6.3 Qilu Pharmaceutical Pemetrexed Drug Product Market Performance
  9.6.4 Qilu Pharmaceutical Business Overview
  9.6.5 Qilu Pharmaceutical Recent Developments
9.7 Biocon
  9.7.1 Biocon Pemetrexed Drug Basic Information
  9.7.2 Biocon Pemetrexed Drug Product Overview
  9.7.3 Biocon Pemetrexed Drug Product Market Performance
  9.7.4 Biocon Business Overview
  9.7.5 Biocon Recent Developments

10 PEMETREXED DRUG MARKET FORECAST BY REGION

10.1 Global Pemetrexed Drug Market Size Forecast
10.2 Global Pemetrexed Drug Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Pemetrexed Drug Market Size Forecast by Country
  10.2.3 Asia Pacific Pemetrexed Drug Market Size Forecast by Region
  10.2.4 South America Pemetrexed Drug Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Pemetrexed Drug by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)

11.1 Global Pemetrexed Drug Market Forecast by Type (2024-2029)
  11.1.1 Global Forecasted Sales of Pemetrexed Drug by Type (2024-2029)
  11.1.2 Global Pemetrexed Drug Market Size Forecast by Type (2024-2029)
  11.1.3 Global Forecasted Price of Pemetrexed Drug by Type (2024-2029)
11.2 Global Pemetrexed Drug Market Forecast by Application (2024-2029)
  11.2.1 Global Pemetrexed Drug Sales (K MT) Forecast by Application
  11.2.2 Global Pemetrexed Drug Market Size (M USD) Forecast by Application (2024-2029)

12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pemetrexed Drug Market Size Comparison by Region (M USD)
Table 5. Global Pemetrexed Drug Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Pemetrexed Drug Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pemetrexed Drug Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Pemetrexed Drug Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2022)
Table 10. Global Market Pemetrexed Drug Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Pemetrexed Drug Sales Sites and Area Served
Table 12. Manufacturers Pemetrexed Drug Product Type
Table 13. Global Pemetrexed Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pemetrexed Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pemetrexed Drug Market Challenges
Table 22. Market Restraints
Table 23. Global Pemetrexed Drug Sales by Type (K MT)
Table 24. Global Pemetrexed Drug Market Size by Type (M USD)
Table 25. Global Pemetrexed Drug Sales (K MT) by Type (2018-2023)
Table 26. Global Pemetrexed Drug Sales Market Share by Type (2018-2023)
Table 27. Global Pemetrexed Drug Market Size (M USD) by Type (2018-2023)
Table 28. Global Pemetrexed Drug Market Size Share by Type (2018-2023)
Table 29. Global Pemetrexed Drug Price (USD/MT) by Type (2018-2023)
Table 30. Global Pemetrexed Drug Sales (K MT) by Application
Table 31. Global Pemetrexed Drug Market Size by Application
Table 32. Global Pemetrexed Drug Sales by Application (2018-2023) & (K MT)
Table 33. Global Pemetrexed Drug Sales Market Share by Application (2018-2023)
Table 34. Global Pemetrexed Drug Sales by Application (2018-2023) & (M USD)
Table 35. Global Pemetrexed Drug Market Share by Application (2018-2023)
Table 36. Global Pemetrexed Drug Sales Growth Rate by Application (2018-2023)
Table 37. Global Pemetrexed Drug Sales by Region (2018-2023) & (K MT)
Table 38. Global Pemetrexed Drug Sales Market Share by Region (2018-2023)
Table 39. North America Pemetrexed Drug Sales by Country (2018-2023) & (K MT)
Table 40. Europe Pemetrexed Drug Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Pemetrexed Drug Sales by Region (2018-2023) & (K MT)
Table 42. South America Pemetrexed Drug Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Pemetrexed Drug Sales by Region (2018-2023) & (K MT)
Table 44. Eli Lilly and Company Pemetrexed Drug Basic Information
Table 45. Eli Lilly and Company Pemetrexed Drug Product Overview
Table 46. Eli Lilly and Company Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Eli Lilly and Company Business Overview
Table 48. Eli Lilly and Company Pemetrexed Drug SWOT Analysis
Table 49. Eli Lilly and Company Recent Developments
Table 50. Pfizer Pemetrexed Drug Basic Information
Table 51. Pfizer Pemetrexed Drug Product Overview
Table 52. Pfizer Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Pfizer Business Overview
Table 54. Pfizer Pemetrexed Drug SWOT Analysis
Table 55. Pfizer Recent Developments
Table 56. Teva Pemetrexed Drug Basic Information
Table 57. Teva Pemetrexed Drug Product Overview
Table 58. Teva Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Teva Business Overview
Table 60. Teva Pemetrexed Drug SWOT Analysis
Table 61. Teva Recent Developments
Table 62. Eagle Pharmaceuticals Pemetrexed Drug Basic Information
Table 63. Eagle Pharmaceuticals Pemetrexed Drug Product Overview
Table 64. Eagle Pharmaceuticals Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Eagle Pharmaceuticals Business Overview
Table 66. Eagle Pharmaceuticals Pemetrexed Drug SWOT Analysis
Table 67. Eagle Pharmaceuticals Recent Developments
Table 68. APOTEX Pemetrexed Drug Basic Information
Table 69. APOTEX Pemetrexed Drug Product Overview
Table 70. APOTEX Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. APOTEX Business Overview
Table 72. APOTEX Pemetrexed Drug SWOT Analysis
Table 73. APOTEX Recent Developments
Table 74. Qilu Pharmaceutical Pemetrexed Drug Basic Information
Table 75. Qilu Pharmaceutical Pemetrexed Drug Product Overview
Table 76. Qilu Pharmaceutical Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Qilu Pharmaceutical Business Overview
Table 78. Qilu Pharmaceutical Recent Developments
Table 79. Biocon Pemetrexed Drug Basic Information
Table 80. Biocon Pemetrexed Drug Product Overview
Table 81. Biocon Pemetrexed Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Biocon Business Overview
Table 83. Biocon Recent Developments
Table 84. Global Pemetrexed Drug Sales Forecast by Region (2024-2029) & (K MT)
Table 85. Global Pemetrexed Drug Market Size Forecast by Region (2024-2029) & (M USD)
Table 86. North America Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K MT)
Table 87. North America Pemetrexed Drug Market Size Forecast by Country (2024-2029) & (M USD)
Table 88. Europe Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K MT)
Table 89. Europe Pemetrexed Drug Market Size Forecast by Country (2024-2029) & (M USD)
Table 90. Asia Pacific Pemetrexed Drug Sales Forecast by Region (2024-2029) & (K MT)
Table 91. Asia Pacific Pemetrexed Drug Market Size Forecast by Region (2024-2029) & (M USD)
Table 92. South America Pemetrexed Drug Sales Forecast by Country (2024-2029) & (K MT)
Table 93. South America Pemetrexed Drug Market Size Forecast by Country (2024-2029) & (M USD)
Table 94. Middle East and Africa Pemetrexed Drug Consumption Forecast by Country (2024-2029) & (Units)
Table 95. Middle East and Africa Pemetrexed Drug Market Size Forecast by Country (2024-2029) & (M USD)
Table 96. Global Pemetrexed Drug Sales Forecast by Type (2024-2029) & (K MT)
Table 97. Global Pemetrexed Drug Market Size Forecast by Type (2024-2029) & (M USD)
Table 98. Global Pemetrexed Drug Price Forecast by Type (2024-2029) & (USD/MT)
Table 99. Global Pemetrexed Drug Sales (K MT) Forecast by Application (2024-2029)
Table 100. Global Pemetrexed Drug Market Size Forecast by Application (2024-2029) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Pemetrexed Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pemetrexed Drug Market Size (M USD), 2018-2029
Figure 5. Global Pemetrexed Drug Market Size (M USD) (2018-2029)
Figure 6. Global Pemetrexed Drug Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pemetrexed Drug Market Size by Country (M USD)
Figure 11. Pemetrexed Drug Sales Share by Manufacturers in 2022
Figure 12. Global Pemetrexed Drug Revenue Share by Manufacturers in 2022
Figure 13. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Pemetrexed Drug Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pemetrexed Drug Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pemetrexed Drug Market Share by Type
Figure 18. Sales Market Share of Pemetrexed Drug by Type (2018-2023)
Figure 19. Sales Market Share of Pemetrexed Drug by Type in 2022
Figure 20. Market Size Share of Pemetrexed Drug by Type (2018-2023)
Figure 21. Market Size Market Share of Pemetrexed Drug by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pemetrexed Drug Market Share by Application
Figure 24. Global Pemetrexed Drug Sales Market Share by Application (2018-2023)
Figure 25. Global Pemetrexed Drug Sales Market Share by Application in 2022
Figure 26. Global Pemetrexed Drug Market Share by Application (2018-2023)
Figure 27. Global Pemetrexed Drug Market Share by Application in 2022
Figure 28. Global Pemetrexed Drug Sales Growth Rate by Application (2018-2023)
Figure 29. Global Pemetrexed Drug Sales Market Share by Region (2018-2023)
Figure 30. North America Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Pemetrexed Drug Sales Market Share by Country in 2022
Figure 32. U.S. Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Pemetrexed Drug Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Pemetrexed Drug Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Pemetrexed Drug Sales Market Share by Country in 2022
Figure 37. Germany Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Pemetrexed Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Pemetrexed Drug Sales Market Share by Region in 2022
Figure 44. China Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Pemetrexed Drug Sales and Growth Rate (K MT)
Figure 50. South America Pemetrexed Drug Sales Market Share by Country in 2022
Figure 51. Brazil Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Pemetrexed Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Pemetrexed Drug Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Pemetrexed Drug Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Pemetrexed Drug Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Pemetrexed Drug Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Pemetrexed Drug Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Pemetrexed Drug Market Share Forecast by Type (2024-2029)
Figure 65. Global Pemetrexed Drug Sales Forecast by Application (2024-2029)
Figure 66. Global Pemetrexed Drug Market Share Forecast by Application (2024-2029)


More Publications